INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business UpdateCompany to Host Conference Call Today, March 28, at 4:30pm ETBOCA RATON, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the Company ), a clinical-stage immunology company...
Globe Newswire•4 months ago